Autres langues Abbott Laboratories

Actions

ABT

US0028241000

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE 22:04:29 09/09/2026			Varia. 5j.	Varia. 1 janv.
105,23 ^USD	-0,27 %		-4,74 %	-16,01 %

08/09	Abbott reçoit l'approbation de la FDA pour le cathéter d'ablation TactiFlex Duo destiné au traitement des troubles du rythme cardiaque	CI
08/09	Abbott Laboratories obtient l'approbation de la FDA pour son cathéter d'ablation à double énergie contre la fibrillation auriculaire	MT

Autres langues

08/09	Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm
08/09	Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms
08/09	Abbott Laboratories Wins FDA Approval for Dual-Energy AFib Catheter
04/09	US companies face rise in cyber attacks
01/09	Mead Johnson wins US federal bellwether trial over preterm infant formula Enfamil
01/09	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat
01/09	Oncology firm Novocure says cyberattack exposed US patient records
01/09	Reckitt shares rise after US jury backs unit Mead Johnson in baby formula case
01/09	Colorectal Cancer Alliance and Abbott Launch Online Hub Explaining Unexpected Home Delivery Of Colorectal Cancer Screening Kits
31/08	Abbott Launches Similac 360 Total Care Made with Whole Milk Ready-To-Feed Liquid Infant Formula in the United States
31/08	Abbott Laboratories : Late-breaking data for Abbott’s TactiFlex™ Duo Ablation Catheter reveal positive outcomes for treating complex AFib cases
31/08	Abbott Laboratories Introduces Similac 360 Total Care Made With Whole Milk in US
31/08	Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula
31/08	Abbott Presents Positive 12-Month Outcomes for Tactiflex Duo Ablation Catheter in Treating Complex Afib Cases
27/08	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing
27/08	Abbott Laboratories' Stroke Treatment Device Receives CE Mark
27/08	Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke
26/08	Analyst recommendations: Nvidia, Intuit, BofA, Abbott Laboratories, Google…
26/08	Boston Scientific hit by cyberattack, global operations affected
26/08	FDA clears Abbott's first sensor to continuously measure glucose and ketones
25/08	Abbott Receives Fda Authorization for Libre Duo 10 Day Dual Glucose-Ketone Sensing Technology
25/08	Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor
25/08	FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients
25/08	Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
21/08	Global markets live: Walmart, Nvidia, Ross Stores, SpaceX, Delta Air Lines…